Short, Lipidated Dendrimeric γ-AApeptides as New Antimicrobial Peptidomimetics

Int J Mol Sci. 2023 Mar 29;24(7):6407. doi: 10.3390/ijms24076407.

Abstract

Antibiotic resistance is one of the most significant issues encountered in global health. There is an urgent demand for the development of a new generation of antibiotic agents combating the emergence of drug resistance. In this article, we reported the design of lipidated dendrimeric γ-AApeptides as a new class of antimicrobial agents. These AApeptides showed excellent potency and broad-spectrum activity against both Gram-positive bacteria and Gram-negative bacteria, including methicillin-resistant Staphylococcus aureus (MRSA). The mechanistic studies revealed that the dendrimeric AApeptides could kill bacteria rapidly through the permeabilization of bacterial membranes, analogous to host-defense peptides (HDPs). These dendrimers also did not induce antibiotic resistance readily. The easy access to the synthesis, together with their potent and broad-spectrum activity, make these lipidated dendrimeric γ-AApeptides a new generation of antibacterial agents.

Keywords: antibiotic resistance; broad spectrum activity; dendrimeric γ-AApeptides.

MeSH terms

  • Anti-Bacterial Agents / pharmacology
  • Anti-Infective Agents* / pharmacology
  • Bacteria
  • Methicillin-Resistant Staphylococcus aureus*
  • Microbial Sensitivity Tests
  • Peptidomimetics* / pharmacology

Substances

  • Peptidomimetics
  • gamma-AApeptide
  • Anti-Infective Agents
  • Anti-Bacterial Agents